TGF-beta receptor inhibitors (Biogen Idec)

N/A

Report date: 2025/06/20 20:01:04
NME

Base Information

Drug NameTGF-beta receptor inhibitors (Biogen Idec)
Drug Alias NameTGF-beta receptor inhibitors (Biogen)HTS-466284SM-16
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsTransforming growth factor beta receptors antagonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsFibrosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogen Inc
Active IndicationsN/A
Inactive IndicationsFibrosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A